A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients With Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery NEOPOLIS

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT07195734

Study #:
STUDY00162300

Start Date:
Mar 19, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07195734

View Complete Trial Details & Eligibility at ClinicalTrials.gov